KeyBanc analyst Brett Fishbin lowered the firm’s price target on ICU Medical (ICUI) to $173 from $191 to reflect lower industry/peer multiples, while keeping an Overweight rating on the shares. The firm remains encouraged by ICU’s significant progress in demonstrating increased operational and financial stability.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICUI: